🔎 Trials Near Me

Akèy › Neuroblastom › Texas › Houston

Etid klinik pou Neuroblastom nan Houston, TX

7 etid pou Neuroblastom ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ap rekriteFaz 3
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
  • UT MD Anderson Cancer Center, Houston
Jiska laj 30 · Tout sèks · Mizajou Oct 2, 2026 · NCT06172296

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Ap rekriteFaz 1/2
  • University of Texas MD Anderson Cancer Center ( Site 1007), Houston
6 Months – 25 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT06395103

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Ap rekriteFaz 3
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
365 Days – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ap rekriteFaz 1/2
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

Ap rekriteFaz 1/2
  • Texas Children's Hospital, Houston
Laj 1 a 30 · Tout sèks · Mizajou Jul 22, 2026 · NCT06721689

NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma

Ap rekriteFaz 1
  • Texas Children's Hospital, Houston
Laj 1 a 24 · Tout sèks · Mizajou Jul 21, 2026 · NCT07211737

GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma

Ap rekriteFaz 1
  • Texas Children's Hospital, Houston
Laj 1 a 21 · Tout sèks · Mizajou Sep 19, 2025 · NCT03294954

Etid Neuroblastom nan lòt vil

Lòt etid nan Houston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.